The FDA's 2023 and 2024 actions against compounding pharmacies cited concerns about purity, potency, and sterility of BPC-157 products 3
Both peptides maintain stability across the same pH range (4.0-8.0), so there are no compatibility concerns in the blended format
The peptide upregulates VEGF expression and promotes endothelial cell migration, creating the vascular infrastructure necessary for sustained tissue repair
The best results occur when BPC-157 is used for the right injury, at the right time, with the right supporting plan
[4,6] Studies show increased collagen synthesis, improved tendon-to-bone healing, and faster recovery from transection injuries
The FDA says it lacks sufficient information to know whether the drug would cause harm when administered to humans. Both Dr